全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Obstetrical Healthcare Personnel's Attitudes and Perceptions on Maternal Vaccination with Tetanus-Diphtheria-Acellular Pertussis and Influenza

DOI: 10.1155/2013/586356

Full-Text   Cite this paper   Add to My Lib

Abstract:

Objectives. To assess perceptions of obstetrical healthcare personnel (HCP) regarding routine delivery of Tdap and influenza vaccines to pregnant and postpartum women and identify perceived barriers to vaccination. Methods. Anonymous Web-based survey of obstetricians and nurses caring for pregnant and/or postpartum women. Results. We contacted 342 HCP and received 163 (48%) completed surveys (33/142 (23%) obstetricians, 130/200 (65%) nurses). Among obstetricians, 72% and 63% thought it was “beneficial” to immunize postpartum women against influenza and pertussis, respectively. Only 8% reported vaccinating >75% of pregnant women in their care against influenza. Similarly, <1% of obstetricians reported vaccinating against pertussis. Of all HCP surveyed, 92% and 58% were familiar with ACIP recommendations for influenza and pertussis, respectively. Reported perceived barriers included patient refusal to be vaccinated, reimbursement difficulties, and discomfort in providing vaccine education. Ninety-four percent of respondents agreed that standing orders would be helpful to ensure postpartum vaccination. Conclusions. HCP were less familiar with ACIP recommendations for Tdap compared to influenza vaccines. Substantial discrepancy existed between perceived benefit of vaccination and reported immunization practices. Most identified barriers could be addressed with provider training; however, other barriers require review and changes in systematic policies related to vaccine reimbursement. 1. Introduction The Advisory Committee on Immunization Practices (ACIP) recommends influenza vaccination of pregnant or postpartum women as well as household contacts of infants of <1?year of age [1, 2]. The ACIP also recommends tetanus toxoid, reduced diphtheria toxin, and acellular pertussis vaccine (Tdap) for postpartum women and household contacts of infants [1]. Despite these recommendations, only 11% of pregnant women and approximately 25% of household contacts of high risk individuals were vaccinated against influenza in 2008 [2]. Similarly, only 5% of adult household contacts of an infant of <1 year of age received Tdap in 2008 [3]. Over the last 2 years, influenza vaccination coverage increased to 45% for 2009 monovalent H1N1 vaccine in 2009 and this was sustained for seasonal influenza vaccination in 2010 [4–6], likely secondary to mass media attention during the 2009-2010 H1N1 influenza pandemic. These recommendations exist as pertussis and influenza are highly contagious vaccine-preventable illnesses to which infants of <6 months of old are at risk for significant

References

[1]  T. V. Murphy, B. A. Slade, K. R. Broder et al., “Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the advisory committee on immunization practices (ACIP),” Morbidity and Mortality Weekly Report, vol. 57, no. 4, pp. 1–47, 2008.
[2]  Centers for Disease Control and Prevention, “Prevention and control of influenza. Recommendations of the advisory committee on immunization practices (ACIP),” Morbidity and Mortality Weekly Report, pp. 1–60, 2008.
[3]  Center for Disease Control and Prevention, “Tetanus and pertussis vaccination coverage among adults aged >18 years—United States, 1999 and 2008,” Morbidity and Mortality Weekly Report, vol. 59, no. 40, pp. 1302–1306, 2010.
[4]  Centers for Disease Control and Prevention, “Interim results: influenza A (H1N1) 2009 monovalent vaccination coverage—United States, October-December 2009,” Morbidity and Mortality Weekly Report, vol. 59, pp. 44–48, 2010.
[5]  Centers for Disease Control and Prevention, “Seasonal influenza and 2009 H1N1 influenza vaccination coverage among pregnant women—10 States, 2009-10 influenza season,” Morbidity and Mortality Weekly Report, vol. 59, pp. 1541–1545, 2010.
[6]  H. Ding, T. A. Santibanez, D. J. Jamieson et al., “Influenza vaccination coverage among pregnant women—national 2009 H1N1 flu survey (NHFS),” The American Journal of Obstetrics and Gynecology, vol. 204, no. 6, supplement 1, pp. S96–S106, 2011.
[7]  A. M. Wendelboe, E. Njamkepo, A. Bourillon et al., “Transmission of Bordetella pertussis to young infants,” Pediatric Infectious Disease Journal, vol. 26, no. 4, pp. 293–299, 2007.
[8]  E. A. Mortimer Jr., “Pertussis and its prevention: a family affair,” Journal of Infectious Diseases, vol. 161, no. 3, pp. 473–479, 1990.
[9]  E. L. Hewett and K. M. Edward, “Clinical practice: pertussis-not just for kids,” The New England Journal of Medicine, vol. 352, pp. 1215–1222, 2005.
[10]  K. A. Poehling, K. M. Edwards, G. A. Weinberg et al., “The underrecognized burden of influenza in young children,” The New England Journal of Medicine, vol. 355, no. 1, pp. 31–40, 2006.
[11]  K. L. Nichol and R. Zimmerman, “Generalist and subspecialist physicians' knowledge, attitudes, and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients,” Archives of Internal Medicine, vol. 161, no. 22, pp. 2702–2708, 2001.
[12]  R. Prislin, P. R. Nader, M. de Guire et al., “Physicians' immunization knowledge, attitudes, and practices. A valid and internally consistent measurement tool,” The American Journal of Preventive Medicine, vol. 17, no. 2, pp. 151–152, 1999.
[13]  R. C. Chi and K. M. Neuzil, “The association of sociodemographic factors and patient attitudes on influenza vaccination rates in older persons,” The American Journal of the Medical Sciences, vol. 327, no. 3, pp. 113–117, 2004.
[14]  R. Lyn-Cook, E. A. Halm, and J. P. Wisnivesky, “Determinants of adherence to influenza vaccination among inner-city adults with persistent asthma,” Primary Care Respiratory Journal, vol. 16, no. 4, pp. 229–235, 2007.
[15]  R. K. Zimmerman, T. A. Santibanez, J. E. Janosky et al., “What affects influenza vaccination rates among older patients? An analysis from inner-city, suburban, rural, and veterans affairs practices,” The American Journal of Medicine, vol. 114, no. 1, pp. 31–38, 2003.
[16]  P. G. Szilagyi, M. K. Iwane, S. E. Humiston et al., “Time spent by primary care practices on pediatric influenza vaccination visits: implications for universal influenza vaccination,” Archives of Pediatrics and Adolescent Medicine, vol. 157, no. 2, pp. 191–195, 2003.
[17]  A. R. Hinman, W. A. Orenstein, and L. Rodewald, “Financing immunizations in the United States,” Clinical Infectious Diseases, vol. 38, no. 10, pp. 1440–1446, 2004.
[18]  D. R. Johnson, K. L. Nichol, and K. Lipczynski, “Barriers to adult immunization,” The American Journal of Medicine, vol. 121, no. 7, supplement 2, pp. S28–S35, 2008.
[19]  M. L. Power, M. A. Leddy, B. L. Anderson, S. A. Gall, B. Gonik, and J. Schulkin, “Obstetrician-gynecologists' practices and perceived knowledge regarding immunization,” The American Journal of Preventive Medicine, vol. 37, no. 3, pp. 231–234, 2009.
[20]  S. J. Schrag, A. E. Fiore, B. Gonik et al., “Vaccination and perinatal infection prevention practices among obstetrician-gynecologists,” Obstetrics and Gynecology, vol. 101, no. 4, pp. 704–710, 2003.
[21]  B. Gonik, T. Jones, and D. Contreras, “The obstetrician-gynecologist's role in vaccine-preventable diseases and immunization,” Morbidity and Mortality Weekly Report, vol. 54, no. 41, pp. 1050–1052, 2005.
[22]  S. J. Clark, S. Adolphe, M. M. Davis, A. E. Cowan, and K. Kretsinger, “Attitudes of US obstetricians toward a combined tetanus-diphtheria-acellular pertussis vaccine for adults,” Infectious Diseases in Obstetrics and Gynecology, vol. 2006, Article ID 87040, 5 pages, 2006.
[23]  K. L. Nichol, “Ten-year durability and success of an organized program to increase influenza and pneumococcal vaccination rates among high-risk adults,” The American Journal of Medicine, vol. 105, no. 5, pp. 385–392, 1998.
[24]  Center for Disease Control and Prevention, “Missed opportunities for pneumococcal and influenza vaccination of Medicare pneumonia inpatients—12 Western states, 1995,” Morbidity and Mortality Weekly Report, vol. 46, pp. 919–923, 1997.
[25]  H. G. Bloom, D. A. Wheeler, and J. Linn, “A managed care organization's attempt to increase influenza and pneumococcal immunizations for older adults in an acute care setting,” Journal of the American Geriatrics Society, vol. 47, no. 1, pp. 106–110, 1999.
[26]  C. M. Healy, M. A. Rench, L. A. Castagnini, and C. J. Baker, “Pertussis immunization in a high-risk postpartum population,” Vaccine, vol. 27, no. 41, pp. 5599–5602, 2009.
[27]  Center for Disease Control and Prevention, “Use of standing orders programs to increase adult vaccination rates. Recommendations of the advisory committee on immunization practices,” Morbidity and Mortality Weekly Report, vol. 49, no. 1, pp. 15–26, 2000.
[28]  P. R. Dexter, S. M. Perkins, K. S. Maharry, K. Jones, and C. J. McDonald, “Inpatient computer-based standing orders vs physician reminders to increase influenza and pneumococcal vaccination rates: a randomized trial,” The Journal of the American Medical Association, vol. 292, no. 19, pp. 2366–2371, 2004.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133